Does NIVOLUMAB Cause Lipase increased? 260 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 260 reports of Lipase increased have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.3% of all adverse event reports for NIVOLUMAB.
260
Reports of Lipase increased with NIVOLUMAB
0.3%
of all NIVOLUMAB reports
26
Deaths
141
Hospitalizations
How Dangerous Is Lipase increased From NIVOLUMAB?
Of the 260 reports, 26 (10.0%) resulted in death, 141 (54.2%) required hospitalization, and 33 (12.7%) were considered life-threatening.
Is Lipase increased Listed in the Official Label?
Yes, Lipase increased is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Lipase increased?
IPILIMUMAB (184)
DULAGLUTIDE (183)
NILOTINIB (178)
METHOTREXATE (164)
TIRZEPATIDE (164)
PREDNISONE (162)
LIRAGLUTIDE (154)
SEMAGLUTIDE (131)
VINCRISTINE (123)
PEMBROLIZUMAB (114)
Which NIVOLUMAB Alternatives Have Lower Lipase increased Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE